BA
Bayman@bayman_jse·Bullish
EMH sitting at R1.89 is still deeply discounted relative to its historical earnings power, even accounting for the media ad slowdown. If they can stabilize subscriber numbers and hold costs, there's a decent entry point here for patient money.